Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CIMZIA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/CIMZIA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Approved

STANDARD

CIMZIA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Ucb Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 1, 2021
Approval ID: 2bf948014ff2f36c
Company: Ucb Pharma
Type: Standard

Approval Details

Approval Id: 2bf948014ff2f36c
Drug Cima Aemps Name: CIMZIA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number: 109544005IP
Holder Company Name: Ucb Pharma
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/ucb-pharma-sa
Authorization Date: 2021-11-01
Dosage Form: SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose: 200 mg/ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Ucb Pharma
Company Detail Path: /organization/ucb-pharma-sa

Company Information

Pharmaceutical Company Name: UCB S.A.
Name En: UCB S.A.
Country Name: Belgium
City Name: Brussels
Address: Brussels, Belgium
Website: https://www.ucb.com

Active Ingredients

CERTOLIZUMAB PEGOL

200 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 1, 2021

Approval ID

2bf948014ff2f36c

Type

Standard

Back to CIMA-AEMPS Approvals